Medicare to pay hundreds of thousands for CAR-T therapies – BioPharma Dive
FiercePharma |
Medicare to pay hundreds of thousands for CAR–T therapies
BioPharma Dive CAR-T therapies work by taking a patient's T–cells, engineering them to better combat cancer, and infusing them back into the body. The process is highly complex, highly expensive and, as seen in clinical investigations, highly effective. The approval … US Medicare sets outpatient rate for Yescarta reimbursement |
